Difference between revisions of "OctPGMS pathway control state"
Line 21: | Line 21: | ||
* [[SUIT-RP2]]_'''6S''': 1D 2Oct 3Mtit 3c (3NADH) 4P 5G '''<u>6S</u>''' 7U 8Gp 9Rot 10Ama 11Tm 12Azd''' | * [[SUIT-RP2]]_'''6S''': 1D 2Oct 3Mtit 3c (3NADH) 4P 5G '''<u>6S</u>''' 7U 8Gp 9Rot 10Ama 11Tm 12Azd''' | ||
== | == PGMSOct(E) == | ||
* [[Cross-linked respiratory states]] in the [[SUIT reference assay]] | * [[Cross-linked respiratory states]] in the [[SUIT reference assay]] | ||
# [[SUIT-RP1]]_'''6S''': 1PM 2D 2c (2NADH) 3U 4Oct 5G '''<u>6S</u>''' 7Rot 8Gp 9Ama 10Tm 11Azd | # [[SUIT-RP1]]_'''6S''': 1PM 2D 2c (2NADH) 3U 4Oct 5G '''<u>6S</u>''' 7Rot 8Gp 9Ama 10Tm 11Azd |
Revision as of 15:09, 24 January 2016
- high-resolution terminology - matching measurements at high-resolution
OctPGMS pathway control state
Description
PGMSOct: Pyruvate & Glutamate & Malate & Succinate & Octanoylcarnitine.
MitoPathway control: CI&II&FAO
SUIT protocol: SUIT-RP1, SUIT-RP2
This substrate combination supports convergent electron flow to the Q-junction.
Abbreviation: PGMSOct
Reference: MiPNet21.06 SUIT reference assay, SUIT reference protocol
MitoPedia topics: "Respiratory substrate-coupling state" is not in the list (Enzyme, Medium, Inhibitor, Substrate and metabolite, Uncoupler, Sample preparation, Permeabilization agent, EAGLE, MitoGlobal Organizations, MitoGlobal Centres, ...) of allowed values for the "MitoPedia topic" property. Respiratory substrate-coupling state"Respiratory substrate-coupling state" is not in the list (Enzyme, Medium, Inhibitor, Substrate and metabolite, Uncoupler, Sample preparation, Permeabilization agent, EAGLE, MitoGlobal Organizations, MitoGlobal Centres, ...) of allowed values for the "MitoPedia topic" property.
PGMSOct(L)
PGMSOct(P)
- SUIT-RP2_6S: 1D 2Oct 3Mtit 3c (3NADH) 4P 5G 6S 7U 8Gp 9Rot 10Ama 11Tm 12Azd
PGMSOct(E)
- SUIT-RP1_6S: 1PM 2D 2c (2NADH) 3U 4Oct 5G 6S 7Rot 8Gp 9Ama 10Tm 11Azd
- SUIT-RP2_7U: 1D 2Oct 3Mtit 3c (3NADH) 4P 5G 6S 7U 8Gp 9Rot 10Ama 11Tm 12Azd